Since our data suggested that silencing of XAF1 limited the ability of MGMT-hyper GBM cell lines to become adaptively resistant to TMZ, we also wondered if silencing of XAF1 in the cells that were already adaptively resistant could reverse resistance to TMZ. The gene discussed is XAF1; the disease is glioblastoma.